Table of Contents

• FEEDS COMPLIANCE PROGRAM [ARCHIVED]
• CVM ISSUES FIELD ASSIGNMENT TO DETERMINE BACKGROUND DIOXIN LEVELS [ARCHIVED]
• DR. TOLLEFSON PROMOTED TO REAR ADMIRAL [ARCHIVED]
• UPDATE ON LIVESTOCK CLONING [ARCHIVED]
• CVM SCIENTIST CELEBRATES 50 YEARS AT FDA [ARCHIVED]
• CVM AQUACULTURE TEAM TOURS CATFISH FARMS [ARCHIVED]
• RUMINANT FEED ENFORCEMENT ACTIVITIES (BSE) [ARCHIVED]
• ANTIMICROBIAL SUSCEPTIBILITY PATTERNS FOR SALMONELLA ISOLATES OF ANIMAL ORIGIN, NARMS 1999 [ARCHIVED]
• TAKING THE BITE OUT OF FLEAS AND TICKS [ARCHIVED]
• FDA APPROVES FIRST DRUG TO TREAT EPM [ARCHIVED]
• STRICT PRISON SENTENCE GIVEN TO OWNER OF ILLEGAL DAIRY OPERATION [ARCHIVED]
• FDA SEEKING COMMENTS ON IMPORT TOLERANCES [ARCHIVED]
• REGULATORY ACTIVITIES - September/October 2001 [ARCHIVED]
• CONSENT DECREE SIGNED IN TISSUE RESIDUE CASE AGAINST CALIFORNIA DAIRIES [ARCHIVED]
• CHARACTERIZATION OF CHLORAMPHENICOL RESISTANCE IN ESCHERICHIA COLI ASSOCIATED WITH DIARRHEA IN NEONATAL SWINE [ARCHIVED]
• IDENTIFICATION AND EXPRESSION OF CEPHAMYCINASE BLA CMY GENES IN ESCHERICHIA COLI AND SALMONELLA ISOLATED FROM FOOD ANIMALS AND GROUND MEATS [ARCHIVED]
• ESCHERICHIA COLI O157:H7 MARR: GENETIC ANALYSIS OF ITS ROLE IN GROWTH IN THE PRESENCE AND ABSENCE OF ANTIBIOTICS [ARCHIVED]
• LETTER TO THE EDITOR [ARCHIVED]
• NEW ANIMAL DRUG APPROVALS - September/October 2001 [ARCHIVED]
• ABBREVIATED NEW ANIMAL DRUG APPROVALS - September/October 2001 [ARCHIVED]
• SUPPLEMENTAL NEW ANIMAL DRUG APPROVALS - September/October 2001 [ARCHIVED]